Connect with us

Earnings

Johnson & Johnson’s Vaccine Is on Hold But lts Businesses Emerged Healthier From the Pandemic

On Tuesday, Johnson and Johnson (NYSE: JNJ) reported $100 million in first-quarter sales of its single shot Covid-19 vaccine that’s...

Advertisement

Submit an Article

Send us your details and the subject of your article and an IAM editor will be in touch with you shortly